Lindsey Elizabeth Roeker

机构：Mayo Clinic, Memorial Sloan Kettering Cancer Center, WinnMed, Mayo Clinic in Arizona · ORCID：0000-0002-3806-059X

发表论文 227 篇 · 总被引 3840 次 · h-index 29

代表论文

• Genomic determinants of response and resistance to pirtobrutinib in relapsed/refractory chronic lymphocytic leukemia (2025 · Blood · 被引 7)
• Pirtobrutinib in Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL): Final update from the Phase 1/2 BRUIN study (2025 · Blood · 被引 6)
• Can minimal residual disease be used to tailor therapy duration for chronic lymphocytic leukemia patients? (2026 · Expert Review of Hematology · 被引 1)
• Patient-reported outcomes among patients with mantle cell lymphoma or chronic lymphocytic leukemia receiving pirtobrutinib in the BRUIN phase 1/2 study: final analysis (2025 · Current Medical Research and Opinion · 被引 1)
• Updated results from a Phase II study of minimal residual disease-guided venetoclax + obinutuzumab for the initial treatment of fit patients with chronic lymphocytic leukemia (2025 · Blood · 被引 1)
• Molecular and structural basis of pan-resistance to BTK targeting therapies via BTK A428D mutation (2025 · Blood · 被引 1)